Latest & greatest articles for depression

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on depression or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on depression and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for depression

121. Anxiety and depression in spasmodic dysphonia patients Full Text available with Trip Pro

Anxiety and depression in spasmodic dysphonia patients Experts used to believe that spasmodic dysphonia (SD) was a psychogenic disorder. Although SD is now established as a neurological disorder, the rates of co-morbid anxiety and depression range from 7.1% to 62%. Our objective was to study the prevalence and risk factors associated with these mood disorders in SD patients.Retrospective.SD patients who presented for botulinum toxin injections were recruited. Demographic data, Hospital Anxiety (...) and Depression Scale (HADS), Voice Handicap Index-10 (VHI-10), General Self-Efficacy scale (GSES), Disease Specific Self-Efficacy in Spasmodic Dysphonia scale (DSSE), and Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) were collected.One hundred and forty two patients (age (59.2 ± 13.6) years, 25.4% male) had VHI-10 of 26.3 ± 6.9 (mean ± standard deviation), GSES 33.2 ± 5.8, CAPE-V 43.9 ± 20.9, HADS anxiety 6.7 ± 3.7, and HADS depression 3.6 ± 2.8. About 19 (13.4%) and 4 (2.8%) had symptoms

2018 World journal of otorhinolaryngology - head and neck surgery

122. Assessment of outcome measures for cost–utility analysis in depression: mapping depression scales onto the EQ-5D-5L Full Text available with Trip Pro

Assessment of outcome measures for cost–utility analysis in depression: mapping depression scales onto the EQ-5D-5L Many clinical studies including mental health interventions do not use a health state utility instrument, which is essential for producing quality-adjusted life years. In the absence of such utility instrument, mapping algorithms can be applied to estimate utilities from a disease-specific instrument.AimsWe aim to develop mapping algorithms from two widely used depression scales (...) ; the Depression Anxiety Stress Scales (DASS-21) and the Kessler Psychological Distress Scale (K-10), onto the most widely used health state utility instrument, the EQ-5D-5L, using eight country-specific value sets.A total of 917 respondents with self-reported depression were recruited to describe their health on the DASS-21 and the K-10 as well as the new five-level version of the EQ-5D, referred to as the EQ-5D-5L. Six regression models were used: ordinary least squares regression, generalised linear models

2018 BJPsych open

123. Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. Full Text available with Trip Pro

Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. Prescription medications are increasingly used among adults in the United States and many have a potential for causing depression.To characterize use of prescription medications with depression as a potential adverse effect and to assess associations between their use and concurrent depression.Five 2-year cycles (2005-2006 through 2013-2014) of the National Health (...) and Nutrition Examination Survey, representative cross-sectional surveys of US adults aged 18 years or older, were analyzed for use of medications with depression as a potential adverse effect. Multivariable logistic regression examined associations between use of these medications and concurrent depression. Analyses were performed among adults overall, excluding antidepressant users, and among adults treated with antidepressants and with hypertension.Prescription medications with depression as a potential

2018 JAMA

124. Sensitivity and specificity of the Akena Visual Depression Inventory (AViDI-18) in Kampala (Uganda) and Cape Town (South Africa) Full Text available with Trip Pro

Sensitivity and specificity of the Akena Visual Depression Inventory (AViDI-18) in Kampala (Uganda) and Cape Town (South Africa) Visual scales may be particularly useful in screening for depression in patients with low literacy. However, few have been validated and none are in common use.AimModification and validation of a visual scale to screen for depression in low literacy settings.We assessed the validity, reliability and factor loading of a 28-item visual depression inventory using (...) pictorial items depicting depression signs and symptoms. We validated a revised scale comprised of 18 items known as the Akena Visual Depression Inventory (AViDI-18) against a structured diagnostic interview (Mini-International Neuropsychiatric Inventory) in 343 patients in Kampala (Uganda) and Cape Town (South Africa).The 18 pictorial items had acceptable validity and reliability. The area under the curve (AUC) score of the AViDI-18 was 0.9. AUC scores were not significantly associated

2018 EvidenceUpdates

125. The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease Full Text available with Trip Pro

The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease Peripheral artery disease (PAD) is an increasing health concern with rising incidence globally. Previous studies have shown an association between PAD incidence and depression. The objective of the study was to determine the association of comorbid depression with PAD outcomes (amputation and all-cause mortality rates) in veterans.An observational retrospective cohort of 155,647 (...) patients with incident PAD (2003-2014) from nationwide U.S. Veterans Health Administration hospitals was conducted using the national Veterans Affairs Corporate Data Warehouse. Depression was measured using concurrent International Classification of Diseases, Ninth Revision diagnosis codes 6 months before or after PAD diagnosis. The main outcomes were incident major amputation and all-cause mortality. Crude associations were assessed with Kaplan-Meier plots. The effects of depression adjusted

2018 EvidenceUpdates

126. Pediatric self-inflicted eye trauma due to a major depressive disorder Full Text available with Trip Pro

Pediatric self-inflicted eye trauma due to a major depressive disorder Self-inflicted eye trauma is a serious form of self-harm as it may lead to irreversible visual disability. Diagnosing self-inflicted ocular injuries, in all its forms, can be quite challenging. In this report, we are presenting a 5-year-old girl presented to Sohag University Outpatient Clinic with a history of repeated attacks of bilateral eye redness with blood-tinged strands removed from her eyes. After ocular examination (...) , inferior bulbar conjunctival injection with blood-tinged strands were found. After careful examination of the strands, it was discovered that they were actual threads of cloth due to self-inflicted eye injury. Following psychiatric consultation, the patient was diagnosed as having a major depressive disorder. The case was subject to pharmacological and psychotherapeutic treatment, and showed significant improvement within two months of starting treatment as regard to depressive symptoms and self-injury

2018 Electronic physician

127. Uncertain association between depression and stroke risk in a Chinese mega-study

Uncertain association between depression and stroke risk in a Chinese mega-study Uncertain association between depression and stroke risk in a Chinese mega-study | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional (...) accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Uncertain association between depression and stroke risk in a Chinese mega-study Article Text Causes and risk factors Uncertain association between depression and stroke risk in a Chinese mega-study Eric J Brunner 1 , Irene R

2018 Evidence-Based Mental Health

128. FSRH CEU Statement to published systematic review: The relationship between progestin hormonal contraception and depression: a systematic review

FSRH CEU Statement to published systematic review: The relationship between progestin hormonal contraception and depression: a systematic review FSRH CEU Statement to published systematic review: The relationship between progestin hormonal contraception and depression: a systematic review - Faculty of Sexual and Reproductive Healthcare FSRH CEU Statement to published systematic review: The relationship between progestin hormonal contraception and depression: a systematic review FSRH CEU (...) Statement to published systematic review: The relationship between progestin hormonal contraception and depression: a systematic review Share this article Published on: 9 March 2018 File size: 127kb PDF File type: Clinical Statements Much recent media attention has been given to the subject of a potential association between hormonal contraception and depression. The FSRH CEU monitors and reports relevant emerging evidence. A new systematic review published in Contraception examines the existing

2018 Faculty of Sexual & Reproductive Healthcare

129. Changing response rates in clinical trials of depression: how did the introduction of DSM-III and DSM-III-R influence the outcome?

Changing response rates in clinical trials of depression: how did the introduction of DSM-III and DSM-III-R influence the outcome? Changing response rates in clinical trials of depression: how did the introduction of DSM-III and DSM-III-R influence the outcome? | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see (...) our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Changing response rates in clinical trials of depression: how did the introduction of DSM-III and DSM-III-R influence

2018 Evidence-Based Mental Health

130. Targeted psychological interventions may prevent depression in children and adolescents Full Text available with Trip Pro

Targeted psychological interventions may prevent depression in children and adolescents Targeted psychological interventions may prevent depression in children and adolescents | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Targeted psychological interventions may prevent depression in children and adolescents Article Text Psychological interventions Targeted psychological interventions may prevent depression in children and adolescents

2018 Evidence-Based Mental Health

131. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management Full Text available with Trip Pro

Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management To update clinical practice guidelines to assist primary care (PC) in the screening and assessment of depression. In this second part of the updated guidelines, we address treatment and ongoing management of adolescent depression in the PC setting.By using a combination of evidence- and consensus-based methodologies, the guidelines were updated in 2 phases as informed by (1) current (...) scientific evidence (published and unpublished) and (2) revision and iteration among the steering committee, including youth and families with lived experience.These updated guidelines are targeted for youth aged 10 to 21 years and offer recommendations for the management of adolescent depression in PC, including (1) active monitoring of mildly depressed youth, (2) treatment with evidence-based medication and psychotherapeutic approaches in cases of moderate and/or severe depression, (3) close monitoring

2018 EvidenceUpdates

132. Effect of singing interventions on symptoms of postnatal depression: three-arm randomised controlled trial Full Text available with Trip Pro

Effect of singing interventions on symptoms of postnatal depression: three-arm randomised controlled trial This study assessed whether a novel psychosocial intervention could reduce symptoms of postnatal depression (PND) in the first 40 weeks post-birth. Analyses were carried out of 134 mothers with symptoms of PND randomised into 10 weeks of group singing workshops or group play workshops for them and their babies, or usual care (trial registration: NCT02526407). Overall, among all mothers

2018 EvidenceUpdates

133. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management Full Text available with Trip Pro

Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management To update clinical practice guidelines to assist primary care (PC) clinicians in the management of adolescent depression. This part of the updated guidelines is used to address practice preparation, identification, assessment, and initial management of adolescent depression in PC settings.By using a combination of evidence- and consensus-based (...) methodologies, guidelines were developed by an expert steering committee in 2 phases as informed by (1) current scientific evidence (published and unpublished) and (2) draft revision and iteration among the steering committee, which included experts, clinicians, and youth and families with lived experience.Guidelines were updated for youth aged 10 to 21 years and correspond to initial phases of adolescent depression management in PC, including the identification of at-risk youth, assessment and diagnosis

2018 EvidenceUpdates

134. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. (Abstract)

Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Treatment-resistant major depressive disorder is common; repetitive transcranial magnetic stimulation (rTMS) by use of high-frequency (10 Hz) left-side dorsolateral prefrontal cortex stimulation is an evidence-based treatment for this disorder. Intermittent theta burst stimulation (iTBS) is a newer form of rTMS that can (...) , ON, and University of British Columbia Hospital, Vancouver, BC). Participants were aged 18-65 years, were diagnosed with a current treatment-resistant major depressive episode or could not tolerate at least two antidepressants in the current episode, were receiving stable antidepressant medication doses for at least 4 weeks before baseline, and had an HRSD-17 score of at least 18. Participants were randomly allocated (1:1) to treatment groups (10 Hz rTMS or iTBS) by use of a random permuted block method

2018 Lancet Controlled trial quality: predicted high

135. Antidepressants for preventing postnatal depression. Full Text available with Trip Pro

Antidepressants for preventing postnatal depression. Depression is common in the postnatal period and can lead to adverse effects on the infant and wider family, in addition to the morbidity for the mother. It is not clear whether antidepressants are effective for the prevention of postnatal depression and little is known about possible adverse effects for the mother and infant, particularly during breastfeeding. This is an update of a Cochrane Review last published in 2005.To assess (...) the effectiveness of antidepressant medication for the prevention of postnatal depression, in comparison with any other treatment, placebo or standard care.We searched the Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR ‒ both Studies and References), CENTRAL (Wiley), MEDLINE (OVID), Embase (OVID), PsycINFO (OVID), on 13 February 2018. We also searched the World Health Organization (WHO) trials portal (ICTRP) and ClinicalTrials.gov on 13 February 2018 to identify any additional unpublished

2018 Cochrane

136. Delivering Clinical Practice Guideline-Concordant Care for PTSD and Major Depression in Military Treatment Facilities Full Text available with Trip Pro

Delivering Clinical Practice Guideline-Concordant Care for PTSD and Major Depression in Military Treatment Facilities Providing accessible, high-quality care for psychological health (PH) conditions, such as posttraumatic stress disorder (PTSD) and major depressive disorder (MDD), is important to maintaining a healthy, mission-ready force. It is unclear whether the current system of care meets the needs of service members with PTSD or MDD, and little is known about the barriers to delivering

2018 Rand health quarterly

137. Quality of Care for PTSD and Depression in the Military Health System: Final Report Full Text available with Trip Pro

Quality of Care for PTSD and Depression in the Military Health System: Final Report The U.S. Department of Defense (DoD) strives to maintain a physically and psychologically healthy, mission-ready force, and the care provided by the Military Health System (MHS) is critical to meeting this goal. Attention has been directed to ensuring the quality and availability of programs and services for posttraumatic stress disorder (PTSD) and depression. This study is a comprehensive assessment (...) of the quality of care delivered by the MHS in 2013-2014 for over 38,000 active-component service members with PTSD or depression. The assessment includes performance on 30 quality measures to evaluate the receipt of recommended assessments and treatments. These measures draw on multiple data sources including administrative encounter data, medical record review data, and patient self-reported outcome monitoring data. The assessment identified strengths and areas for improvement for the MHS. In particular

2018 Rand health quarterly

138. Impact of Personality Traits, Anxiety, Depression and Hopelessness Levels on Quality of Life in the Patients with Breast Cancer Full Text available with Trip Pro

Impact of Personality Traits, Anxiety, Depression and Hopelessness Levels on Quality of Life in the Patients with Breast Cancer The aim of this study was to investigate the impacts of personality traits, anxiety, depression and hopelessness levels on quality of life in the patients with breast cancer.The study was performed on 90 patients diagnosed with breast cancer and 90 healthy women. Sociodemographic and Clinical Data Collection Form designed by us, Beck Hopelessness Scale (BHS), Beck (...) Anxiety Scale (BAS), Beck Depression Scale (BDS), Eysenck Personality Inventory (EPI) and Quality of Life Scale-Short Form (SF-36) were administered to patients and to control group.The patients with breast cancer were found to indicate higher levels of anxiety and depression, lower levels of quality of life, and higher scores of personality inventory subscales as compared to the healthy control group. In the patient group, it was identified that the quality of life subscale scores were found

2018 European journal of breast health

139. FSRH CEU Statement: Response to Study on Progestogen-only Contraception Use and Depression

FSRH CEU Statement: Response to Study on Progestogen-only Contraception Use and Depression FSRH CEU Statement: Response to Study on Progestogen-only Contraception Use and Depression - Faculty of Sexual and Reproductive Healthcare FSRH CEU Statement: Response to Study on Progestogen-only Contraception Use and Depression FSRH CEU Statement: Response to Study on Progestogen-only Contraception Use and Depression Share this article Posted 8 March 2018 Date: 08 Mar 2018 Type: FSRH Clinical Guidance (...) and Clinical Statements This statement responds to a recent study that reported that the bulk of evidence does not support an association between progestogen-only contraception (POC) and depression. The study has received media attention and the FSRH CEU considers it important to monitor and report on emerging evidence. A systematic review published in Contraception reported that women who had used progestogen-only contraception (POC) were no more likely to experience depression than women not using POC

2018 Faculty of Sexual & Reproductive Healthcare

140. Season of birth and depression in adulthood: Revisiting historical forerunner evidence for in-utero effects Full Text available with Trip Pro

Season of birth and depression in adulthood: Revisiting historical forerunner evidence for in-utero effects Evidence showing a relationship between season of birth and adult well-being is long-standing, but is now largely overlooked or dismissed. In light of increasingly compelling evidence for the effects of in-utero conditions on adult health, however, it is instructive to revisit the relationship, with an eye toward resolving the reasons for skepticism. This study uses data from the first (...) National Health and Nutritional Examination Survey to examine the effects of month of birth on adult depression. The data correspond to an important time in history and the analysis points to one reason why enthusiasm for birth seasonality in depression has faded: although there was a strong relationship between month of birth and depression in the early 20th century, with spring and summer month births corresponding to significantly more depression, the relationship was largely eliminated by the 1940

2018 SSM - population health